Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine February 2014, 55 (2) 8A;
  • Article
  • Info & Metrics
  • PDF
Loading

Molecular imaging in the breast: Fowler offers an overview of technologic approaches to breast imaging with scintimammography and PET, as well as newer dedicated imaging systems and potential clinical indications and challenges.

Page 177

Digital revolution in radiosynthesis: Reichert provides an assessment of current developments in microfluidic reactors for radiopharmaceutical production and previews an article in this issue of JNM on a mechanically robust microfluidic radiosynthesis device.

Page 181

PRRT outcomes in GEP NETs: Ezziddin and colleagues look at prognostic stratification and predictors of survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors after 177Lu-octreotate peptide receptor radionuclide therapy.

Page 183

Integrated PET/MR for bone lesions: Eiber and colleagues evaluate the diagnostic performance of whole-body integrated 18F-FDG PET/MR specifically for bone lesions and analyze differences in standardized uptake value quantification between PET/MR and PET/CT.

Page 191

18F-FET PET in low-grade astrocytoma: Jansen and colleagues explore the value of dynamic 18F-fluorethyltyrosine PET in early diagnosis and prognosis of astrocytic low-grade glioma.

Page 198

Quantitative somatostatin receptor PET: Velikyan and colleagues compare the performance of 68Ga-DOTATOC and 68Ga-DOTATATE PET in staging and selection of patients for 177Lu-DOTA-octreotate peptide receptor radionuclide therapy.

Page 204

Thyroid blockade and 123I-mIBG imaging: Friedman and colleagues examine the effectiveness of thyroid blockade in subjects undergoing 123I-meta-iodobenzylguanidine imaging and estimate the relative contributions of bound and unbound radioiodine to imaging findings.

Page 211

Interim 18F-FLT PET in NHL: Lee and colleagues report on a prospective study to determine the value of early interim 18F-fluorothymidine PET in predicting response to treatment in patients with non-Hodgkin lymphoma.

Page 216

PET/CT and MR in recurrent prostate cancer: Kitajima and colleagues compare 11C-choline PET/CT with pelvic multiparametric MR imaging for detection of recurrent prostate carcinoma after radical prostatectomy and assess optimal imaging approaches for restaging.

Page 223

PET/CT and survival in prostate cancer: Giovacchini and colleagues look at whether 11C-choline PET/CT predicts survival in prostate carcinoma patients after radical prostatectomy and development of biochemical failure during androgen deprivation therapy.

Page 233

Sorafenib and girentuximab uptake: Muselaers and colleagues describe the effect of the widely used tyrosine kinase inhibitor sorafenib on the tumor-targeting potential of 111In-labeled girentuximab in patients with clear cell renal cell carcinoma.

Page 242

Coronary flow reserve and CAD: Naya and colleagues use 82Rb PET imaging to test the hypothesis that a normal coronary flow reserve is helpful in excluding the presence of high-risk coronary artery disease on angiography.

Page 248

18F-D4-FCH human dosimetry: Challapalli and colleagues report on the safety, biodistribution, and internal radiation dosimetry profiles of this metabolically stable fluoromethylcholine analog in healthy volunteers and describe its potential for clinical PET imaging of choline metabolism.

Page 256

89Zr and multicenter PET/CT studies: Makris and colleagues explore the feasibility of quantitative accuracy and harmonized quality in 89Zr PET/CT images acquired at different sites, with a focus on reliably comparable results in multicenter studies.

Page 264

α therapy with 223Ra-dichloride: Pandit-Taskar and colleagues provide an educational overview of the physical characteristics, clinical data, dosage, administration, optimal patient selection, and toxicities associated with this recently approved radium-labeled agent targeting osseous metastases.

Page 268

Imaging glia in brain metastasis: O’Brien and colleagues examine the spatial and temporal profiles of glial activation during early metastatic growth and assess the potential of the radiolabeled translocator ligand 123I-DPA-713 for early SPECT detection of brain metastases.

Page 275

111In-RGD2 and integrin αvβ3-negative tumors: Terry and colleagues describe studies with 111In-RGD2 imaging of integrin αvβ3 expression only on blood vessels in tumor xenografts in which tumor cells were integrin αvβ3-negative, allowing specific visualization of angiogenesis.

Page 281

Motion correction for awake PET: Jin and colleagues report on the design and validation of 2 motion-correction algorithms for unrestrained, awake brain PET imaging in nonhuman primates.

Page 287

PDGFRβ imaging with Affibody molecules: Tolmachev and colleagues assess the feasibility of in vivo PET imaging of platelet-derived growth factor receptor β expression using a small nonimmunoglobulin affinity protein.

Page 294

In vivo PET tracking of Th1 cells: Griessinger and colleagues describe the development and validation of protocols minimizing the inhibitory effects of 64Cu-PTSM labeling on T cell function and facilitating PET imaging of T cell “homing” patterns.

Page 301

68Ga-NOTA-UBI29-41 PET and infection: Ebenhan and colleagues detail the development of a ubiquicidin-based tracer and its initial validation in animal studies as a PET/CT tracer for differentiation of infection from inflammation.

Page 308

Adenosine A1R occupancy by (ant)agonists: Paul and colleagues explore the question of whether 11C-MPDX PET can be used to visualize adenosine A1 receptors occupancy by nonradioactive agonists and antagonists in rats.

Page 315

Synthesis of 18F-FLT on microchips: Javed and colleagues detail the multistep synthesis of 18F-FLT with high yield on a compact electrowetting-on-dielectric microfluidic radiosynthesizer, with the potential for PET probe production outside of cyclotrons and specialized radiochemistry facilities.

Page 321

PET/MR image attenuation correction: Mollet and colleagues describe the use of an annulus-shaped PET transmission source inside the field of view of PET for accurate attenuation correction at 511 keV in time-of-flight PET/MR imaging in humans.

Page 329

NCI/SNMMI workshop on targeted radionuclide therapy: Fahey and colleagues offer an overview of insights and discussions from a 2013 joint forum designed to focus on the current status of and strategies to advance radionuclide therapy.

Page 337

  • © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (2)
Journal of Nuclear Medicine
Vol. 55, Issue 2
February 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Feb 2014, 55 (2) 8A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Feb 2014, 55 (2) 8A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • A Molecular Approach to Breast Imaging
  • Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
  • Early Determination of Prognosis by Interim 3′-Deoxy-3′-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma
  • Biodistribution and Radiation Dosimetry of Deuterium-Substituted 18F-Fluoromethyl-[1, 2-2H4]Choline in Healthy Volunteers
  • Use of 11C-MPDX and PET to Study Adenosine A1 Receptor Occupancy by Nonradioactive Agonists and Antagonists
  • Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with 223Ra-Dichloride
  • Preserved Coronary Flow Reserve Effectively Excludes High-Risk Coronary Artery Disease on Angiography
  • Improvement of Attenuation Correction in Time-of-Flight PET/MR Imaging with a Positron-Emitting Source
  • Evaluation of Frame-Based and Event-by-Event Motion-Correction Methods for Awake Monkey Brain PET Imaging
  • In Vivo Tracking of Th1 Cells by PET Reveals Quantitative and Temporal Distribution and Specific Homing in Lymphatic Tissue
  • Glial Activation in the Early Stages of Brain Metastasis: TSPO as a Diagnostic Biomarker
  • Multicenter Harmonization of 89Zr PET/CT Performance
  • Imaging Integrin αvβ3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts
  • 11C-Choline PET/CT Predicts Prostate Cancer–Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy
  • Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil
  • Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
  • Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging
  • Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
  • Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
  • Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
  • A Digital Revolution in Radiosynthesis
  • Efficacy of Thyroid Blockade on Thyroid Radioiodine Uptake in 123I-mIBG Imaging
  • Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions
  • Efficient Radiosynthesis of 3′-Deoxy-3′-18F-Fluorothymidine Using Electrowetting-on-Dielectric Digital Microfluidic Chip
  • Imaging of Platelet-Derived Growth Factor Receptor β Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire